Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : All Clowns Must Be Destroyed -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (33464)	5/17/2000 2:20:00 PM
From: LLCF	Read Replies (2) \| Respond to of 42523

OT OT OT: <This is a very controversial subject, with an enormous international focus. Pitted against Celera is the entire community of research scientists at places like NIH and universities and non-profit foundations around the world. They argue, and I agree, that Celera can't patent the human genome, they can only patent modified genes, and novel uses for the genes. In fact, the European patent office just revoked a use patent granted on the neem plant, because it has been used as an antibacterial and fungicidal agent for centuries. > Can't believe this subject popped up here! Anyway, I agree that Clinton was not trying to hold up biotech, just reverse damange he caused by an errant statement that he really has no control over. You're correct that this is very controversal, but the piece above shows only that the patent was revoked due to 'prior art' not because it was a naturally occuring substance, which of course many drugs are. DAK